A detailed history of Axiom Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Axiom Investment Management LLC holds 7,195 shares of GILD stock, worth $633,735. This represents 1.61% of its overall portfolio holdings.

Number of Shares
7,195
Previous 11,014 34.67%
Holding current value
$633,735
Previous $679,000 9.13%
% of portfolio
1.61%
Previous 1.36%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $238,000 - $341,685
-3,819 Reduced 34.67%
7,195 $617,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $133,905 - $152,954
-2,249 Reduced 16.96%
11,014 $679,000
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $2.62 Million - $2.95 Million
-45,445 Reduced 77.41%
13,263 $819,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $235,328 - $294,892
-4,063 Reduced 6.47%
58,708 $3.49 Million
Q4 2021

Feb 02, 2022

SELL
$64.88 - $73.64 $642,701 - $729,477
-9,906 Reduced 13.63%
62,771 $4.56 Million
Q3 2021

Oct 18, 2021

BUY
$67.69 - $73.03 $158,191 - $170,671
2,337 Added 3.32%
72,677 $5.08 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $1.09 Million - $1.19 Million
17,207 Added 32.38%
70,340 $4.84 Million
Q1 2021

May 20, 2021

SELL
$60.0 - $68.46 $1.28 Million - $1.47 Million
-21,405 Reduced 28.72%
53,133 $3.44 Million
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $4.44 Million - $5.07 Million
74,016 Added 14179.31%
74,538 $4.82 Million
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $29,571 - $33,695
522 New
522 $1.21 Million
Q2 2020

Mar 16, 2021

SELL
$72.34 - $84.0 $227,292 - $263,928
-3,142 Closed
0 $0
Q1 2020

Mar 16, 2021

BUY
$62.63 - $80.22 $196,783 - $252,051
3,142 New
3,142 $236,000
Q4 2019

Mar 16, 2021

SELL
$61.62 - $67.78 $202,853 - $223,131
-3,292 Closed
0 $0
Q3 2019

Mar 16, 2021

SELL
$62.51 - $69.0 $247,477 - $273,171
-3,959 Reduced 54.6%
3,292 $208,000
Q2 2019

Mar 16, 2021

SELL
$61.87 - $69.38 $36,255 - $40,656
-586 Reduced 7.48%
7,251 $491,000
Q1 2019

Mar 16, 2021

BUY
$62.53 - $70.05 $94,232 - $105,565
1,507 Added 23.81%
7,837 $510,000
Q4 2018

Oct 23, 2020

BUY
$60.54 - $79.0 $383,218 - $500,070
6,330 New
6,330 $396,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Axiom Investment Management LLC Portfolio

Follow Axiom Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investment Management LLC with notifications on news.